Work-related sun exposure and skin melanoma in the Modena area

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a monocentric, observational case-control project at the Dermatology Clinic of the University Hospital of Modena that enrolls adults undergoing skin biopsy for a suspected melanoma. Participants complete a one-time interview about job history, specific work locations, and sun exposure habits to estimate lifetime occupational and recreational UV radiation exposure. Researchers will classify melanoma subtypes by cumulative solar damage and apply recent INAIL criteria to determine whether certain melanomas can be reported as occupational diseases. The study aims to clarify the link between long-term outdoor work and CSD-associated melanomas and to inform prevention and reporting practices for outdoor workers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Be a patient of the Dermatology Clinic at the University Hospital of Modena.
* Be 18 years of age or older.
* Have undergone a dermatological screening for a suspected skin lesion.
* Be able to understand and sign an informed consent form in italian language.

Exclusion Criteria:

* Be under 18 years of age.
* Have cognitive impairment that prevents providing reliable answers to the interview or recalling past exposures.

Where it's running

• Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze
  Modena, Mo, Italy Recruiting

Study contacts

• Principal investigator: Alberto Modenese, MD. PhD — University of Modena and Reggio Emilia
• Study coordinator: Alberto Modenese, MD, PhD
• Email: alberto.modenese@unimore.it
• Phone: +39 059 205 5461

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early anti-PD1 therapy before surgery in high-risk stage II melanoma

  This study looks at real-world patients with high-risk stage II melanoma to see if starting anti-PD1 therapy before surgery changes outcomes compared with the usual timing.

  Recruiting AC Camargo Cancer Center · São Paulo, São Paulo · NCT07680699

• Guiding melanoma surgery in children using pathology and genetics

  This pediatric phase 2 trial tests whether using tumor pathology and genetic information to classify risk can guide safer, more appropriate surgery for localized skin melanocytic tumors.

  Recruiting at 13 sites Phase 2 Children's Oncology Group · Oakland, California and 12 other locations · NCT07621614

• First-in-human test of KUP-101A in selected advanced skin cancers

  This early study tests KUP-101A to see if it's safe and tolerable and to gather initial clues about its activity in patients with advanced skin cancers.

  Recruiting at 3 sites Phase 1 Kupando GmbH · Munich, Bavaria and 2 other locations · NCT07600476

• Phase 1 of PF-08046033 for advanced non-small-cell lung cancer, esophageal squamous cell cancer, and cutaneous melanoma

  This Phase 1 study will try the experimental antibody-drug conjugate PF-08046033 in adults whose non-small-cell lung cancer, esophageal squamous cell cancer, or cutaneous melanoma has progressed after standard treatments.

  Recruiting at 20 sites Phase 1 Pfizer · Denver, Colorado and 20 other locations · NCT07519655

• Symptoms from immune checkpoint inhibitor therapy for cutaneous melanoma

  We will follow adults with stage IIB–IV cutaneous melanoma who are receiving immune checkpoint inhibitors to see how their symptoms change over time and which factors are linked to worse symptom patterns.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07148245

• Older adults with early-stage melanoma: WLE alone vs. WLE with SLN biopsy

  This trial tests whether doing wide local excision alone works as well as the standard approach of WLE plus sentinel lymph node biopsy for older adults with early-stage melanoma.

  Recruiting at 176 sites Phase 3 Eastern Cooperative Oncology Group · Birmingham, Alabama and 180 other locations · NCT07068074

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.